Sporadic Inclusion Body Myositis (sIBM)
2 clinical trials · Condition
◉ Watch Sporadic Inclusion Body Myositis (sIBM)
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Sporadic Inclusion Body Myositis (NCT06479863) | Austin Neuromuscular Center | 2024-08-08 |
| Study of Long-term Safety, Efficacy Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis (NCT02250443) | Novartis Pharmaceuticals | 2014-03-11 |
Track Sporadic Inclusion Body Myositis (sIBM) automatically
Every clearance here is in the API, with alerts when new ones post.